Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-27 @ 11:10 PM
Study NCT ID:
NCT04667793
Status:
UNKNOWN
Last Update Posted:
2023-04-04
First Post:
2020-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-05
First Submit QC Date:
None
Study First Post Date:
2020-12-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-01
Last Update Post Date:
2023-04-04
Last Update Post Date Type:
ACTUAL